People · Operator

Olli Riikkala

Named in public records as an officer, director or promoter · active 2014–2014 · Biotechnology

1
Companies
1
Filings
$3.7M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Nexstim PlcBiotechnologySeed$3.7M$166.4M2014
Operator network

Olli Riikkala at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Casper Breum · 5 companies · 1 sharedCasper BreumJohan Christenson · 3 companies · 1 sharedJohan ChristensonKen Charhut · 3 companies · 1 sharedKen CharhutRene Kuijten · 2 companies · 1 sharedRene KuijtenGustaf Jarnefelt · 1 companies · 1 sharedGustaf JarnefeltHenri Hannula · 1 companies · 1 sharedHenri HannulaJanne Huhtala · 1 companies · 1 sharedJanne HuhtalaJarmo Laine · 1 companies · 1 sharedJarmo LaineJohn Hardin · 1 companies · 1 sharedJohn HardinJuha Vapaavuori · 1 companies · 1 sharedJuha VapaavuoriKatya ` Smirnyagina · 1 companies · 1 sharedKatya ` Smirnyagi…Mikko Karvinen · 1 companies · 1 sharedMikko KarvinenPetriina Puolakka · 1 companies · 1 sharedPetriina PuolakkaRainer Harjunpaa · 1 companies · 1 sharedRainer HarjunpaaTim Irish · 1 companies · 1 sharedTim IrishNexstim Plc · $3.7M raisedNexstim PlcOlli RiikkalaOR
Olli Riikkala Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Olli Riikkala on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Casper Breum15
Johan Christenson13
Ken Charhut13
Rene Kuijten12
John Hardin11
Henri Hannula11
Gustaf Jarnefelt11
Katya ` Smirnyagina11
Mikko Karvinen11
Juha Vapaavuori11
Janne Huhtala11
Rainer Harjunpaa11
Petriina Puolakka11
Jarmo Laine11
Tim Irish11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.